Modifying Current Indication Prioritization Practices hosted by Syneos Health

The direction of an asset coming out of discovery is the first key business decision organizations make toward ensuring that the asset will be differentiated and value-creating at launch. Drugmakers today can expect to mount a sequence of indication launches over the lifecycle of their asset. But markets are changing at warp speed. There is a need to be more asset-focused and forward-looking when evaluating indication opportunities.

Register for this webinar and learn how to modify current indication prioritization best practices to improve strategic decision making in drug development.